South Dakota's House Committee on Health and Human Services recently approved a Senate bill that would add post-traumatic stress disorder (PTSD) to the list of ailments for which providers could prescribe medical marijuana (MMJ). The measure heads to the governor’s desk for her signature.
What's In The Legislation?
Bill 1, which passed in a 36-32 vote, would allow the state Department of Health to remove a requirement over how the department chooses whether a medical condition qualifies for treatment with cannabis and would allow the legislature to decide on diagnoses for medical marijuana (MMJ) use.
If the legislation is enacted, it would amend the law to include additional debilitating medical conditions for medical cannabis use, such as diagnosis of cancer and seizure disorders, to name a few.
However, Rep. Fred Deutsch pointed out that some studies show that marijuana use in populations with PTSD can increase the rate of suicide. “It's compassionate to vote on the evidence,” Deutsch said. “To do otherwise is not.”
“We’re talking about a good night’s sleep, for heaven’s sake,” replied Rep. Ernie Otten, one of the bill’s sponsors. “So this issue is really just an issue of will. I will not pass medical marijuana. Just why? Because I just will not. I do not agree with it. Or, you start looking at it through a different prism, and you start to see these people as people who are just hurting."
In related news, two measures (GOP-led HB 1172 and 1129) seeking to strike down South Dakota's 'pop-up clinics' for medicinal cannabis were recently killed by members of the Senate committee. Sponsored by Rep. Deutsch, the two bills would have banned ads for medical cannabis that would guarantee a card and telehealth appointments or financial incentives to make an appointment.
Benzinga's Cannabis Capital Conference Is Back
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will go up soon.
Photo: Courtesy Of Jéan Béller On Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.